BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35696646)

  • 1. Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis.
    Frankowski KJ; Patnaik S; Wang C; Southall N; Dutta D; De S; Li D; Dextras C; Lin YH; Bryant-Connah M; Davis D; Wang F; Wachsmuth LM; Shah P; Williams J; Kabir M; Zhu E; Baljinnyam B; Wang A; Xu X; Norton J; Ferrer M; Titus S; Simeonov A; Zheng W; Mathews Griner LA; Jadhav A; Aubé J; Henderson MJ; Rudloff U; Schoenen FJ; Huang S; Marugan JJ
    J Med Chem; 2022 Jun; 65(12):8303-8331. PubMed ID: 35696646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The perinucleolar compartment.
    Pollock C; Huang S
    Cold Spring Harb Perspect Biol; 2010 Feb; 2(2):a000679. PubMed ID: 20182614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The perinucleolar compartment: structure, function, and utility in anti-cancer drug development.
    Makeyev EV; Huang S
    Nucleus; 2024 Dec; 15(1):2306777. PubMed ID: 38281066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis.
    Frankowski KJ; Wang C; Patnaik S; Schoenen FJ; Southall N; Li D; Teper Y; Sun W; Kandela I; Hu D; Dextras C; Knotts Z; Bian Y; Norton J; Titus S; Lewandowska MA; Wen Y; Farley KI; Griner LM; Sultan J; Meng Z; Zhou M; Vilimas T; Powers AS; Kozlov S; Nagashima K; Quadri HS; Fang M; Long C; Khanolkar O; Chen W; Kang J; Huang H; Chow E; Goldberg E; Feldman C; Xi R; Kim HR; Sahagian G; Baserga SJ; Mazar A; Ferrer M; Zheng W; Shilatifard A; Aubé J; Rudloff U; Marugan JJ; Huang S
    Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perinucleolar compartment.
    Pollock C; Huang S
    J Cell Biochem; 2009 May; 107(2):189-93. PubMed ID: 19288520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinucleolar compartment prevalence is a phenotypic pancancer marker of malignancy.
    Norton JT; Pollock CB; Wang C; Schink JC; Kim JJ; Huang S
    Cancer; 2008 Aug; 113(4):861-9. PubMed ID: 18543322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perinucleolar compartment and transformation.
    Kopp K; Huang S
    J Cell Biochem; 2005 May; 95(2):217-25. PubMed ID: 15770648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated high-content screening for compounds that disassemble the perinucleolar compartment.
    Norton JT; Titus SA; Dexter D; Austin CP; Zheng W; Huang S
    J Biomol Screen; 2009 Oct; 14(9):1045-53. PubMed ID: 19762548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinucleolar compartment prevalence has an independent prognostic value for breast cancer.
    Kamath RV; Thor AD; Wang C; Edgerton SM; Slusarczyk A; Leary DJ; Wang J; Wiley EL; Jovanovic B; Wu Q; Nayar R; Kovarik P; Shi F; Huang S
    Cancer Res; 2005 Jan; 65(1):246-53. PubMed ID: 15665301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The perinucleolar compartment (PNC): detection by immunohistochemistry.
    Slusarczyk A; Huang S
    Methods Mol Biol; 2008; 463():161-7. PubMed ID: 18951167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The perinucleolar compartment: RNA metabolism and cancer.
    Norton JT; Huang S
    Cancer Treat Res; 2013; 158():139-52. PubMed ID: 24222357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK13, a Kinase Involved in Pre-mRNA Splicing, Is a Component of the Perinucleolar Compartment.
    Even Y; Escande ML; Fayet C; Genevière AM
    PLoS One; 2016; 11(2):e0149184. PubMed ID: 26886422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of the perinucleolar compartment in cancer cells.
    Slusarczyk A; Kamath R; Wang C; Anchel D; Pollock C; Lewandowska MA; Fitzpatrick T; Bazett-Jones DP; Huang S
    Cold Spring Harb Symp Quant Biol; 2010; 75():599-605. PubMed ID: 21289045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: perinucleolar structures.
    Huang S
    J Struct Biol; 2000 Apr; 129(2-3):233-40. PubMed ID: 10806073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A screening system for anti-metastatic small-molecule compounds based on perinucleolar compartment prevalence in liver cancer cells].
    Liu FF; Lou GH; Liu YN; Zhu HH; Chen Z
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):440-445. PubMed ID: 28763862
    [No Abstract]   [Full Text] [Related]  

  • 16. The dynamic organization of the perinucleolar compartment in the cell nucleus.
    Huang S; Deerinck TJ; Ellisman MH; Spector DL
    J Cell Biol; 1997 Jun; 137(5):965-74. PubMed ID: 9166399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety assessment of metarrestin in dogs: A clinical candidate targeting a subnuclear structure unique to metastatic cancer cells.
    Bourdi M; Rudloff U; Patnaik S; Marugan J; Terse PS
    Regul Toxicol Pharmacol; 2020 Oct; 116():104716. PubMed ID: 32619635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of MRP RNA-protein interactions within the perinucleolar compartment.
    Pollock C; Daily K; Nguyen VT; Wang C; Lewandowska MA; Bensaude O; Huang S
    Mol Biol Cell; 2011 Mar; 22(6):858-67. PubMed ID: 21233287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The perinucleolar compartment and transcription.
    Huang S; Deerinck TJ; Ellisman MH; Spector DL
    J Cell Biol; 1998 Oct; 143(1):35-47. PubMed ID: 9763419
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.